NCT07052760 - Imaging of Solid Tumors Using DLL3 SPECT | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Solid Tumor CancerCastration Resistant Prostate CancerCastration Resistant Prostate Cancer (CRPC)Neuroendocrine (NE) Tumors

Interventions

DRUG

111In-ABD147

Given intravenously (IV) prior to imaging

PROCEDURE

Single-photon emission computed tomography (SPECT)/Computerized tomography (CT)

Undergo imaging

Trial Locations (1)

University of California, San Francisco, San Francisco